Click for best price
Cyclosporine Drugs Market Size, Share 2023
This report contains market size and forecasts of Cyclosporine Drugs in Global, including the following market information:
Global Cyclosporine Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cyclosporine Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Oral Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Cyclosporine Drugs include AbbVie, Allergan, Apotex, Mayne Pharma Group, Mckesson Medical Surgical, Novartis, Otsuka Pharmaceutical, Regenerx Biopharmaceuticals and Santen Pharmaceuticals, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Cyclosporine Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cyclosporine Drugs Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Cyclosporine Drugs Market Segment Percentages, by Type, 2022 (%)
Oral
Parenteral
Global Cyclosporine Drugs Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Cyclosporine Drugs Market Segment Percentages, by Application, 2022 (%)
Transplant Rejection Prophylaxis
Rheumatoid Arthritis
Psoriasis
Dry Eye
Autoimmune Myasthenia Gravis
Others
Global Cyclosporine Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Cyclosporine Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cyclosporine Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cyclosporine Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Allergan
Apotex
Mayne Pharma Group
Mckesson Medical Surgical
Novartis
Otsuka Pharmaceutical
Regenerx Biopharmaceuticals
Santen Pharmaceuticals
Sun Pharmaceuticals Industries
Takeda Pharmaceutical
Teva Pharmaceuticals Industries
United Biotech
Huadong Medicine
| Report Attributes |
Report Details |
| Report Title |
Cyclosporine Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cyclosporine Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cyclosporine Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cyclosporine Drugs Overall Market Size
2.1 Global Cyclosporine Drugs Market Size: 2022 VS 2030
2.2 Global Cyclosporine Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cyclosporine Drugs Players in Global Market
3.2 Top Global Cyclosporine Drugs Companies Ranked by Revenue
3.3 Global Cyclosporine Drugs Revenue by Companies
3.4 Top 3 and Top 5 Cyclosporine Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cyclosporine Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cyclosporine Drugs Players in Global Market
3.6.1 List of Global Tier 1 Cyclosporine Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Cyclosporine Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cyclosporine Drugs Market Size Markets, 2022 & 2030
4.1.2 Oral
4.1.3 Parenteral
4.2 By Type - Global Cyclosporine Drugs Revenue & Forecasts
4.2.1 By Type - Global Cyclosporine Drugs Revenue, 2018-2023
4.2.2 By Type - Global Cyclosporine Drugs Revenue, 2023-2030
4.2.3 By Type - Global Cyclosporine Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cyclosporine Drugs Market Size, 2022 & 2030
5.1.2 Transplant Rejection Prophylaxis
5.1.3 Rheumatoid Arthritis
5.1.4 Psoriasis
5.1.5 Dry Eye
5.1.6 Autoimmune Myasthenia Gravis
5.1.7 Others
5.2 By Application - Global Cyclosporine Drugs Revenue & Forecasts
5.2.1 By Application - Global Cyclosporine Drugs Revenue, 2018-2023
5.2.2 By Application - Global Cyclosporine Drugs Revenue, 2023-2030
5.2.3 By Application - Global Cyclosporine Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cyclosporine Drugs Market Size, 2022 & 2030
6.2 By Region - Global Cyclosporine Drugs Revenue & Forecasts
6.2.1 By Region - Global Cyclosporine Drugs Revenue, 2018-2023
6.2.2 By Region - Global Cyclosporine Drugs Revenue, 2023-2030
6.2.3 By Region - Global Cyclosporine Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cyclosporine Drugs Revenue, 2018-2030
6.3.2 US Cyclosporine Drugs Market Size, 2018-2030
6.3.3 Canada Cyclosporine Drugs Market Size, 2018-2030
6.3.4 Mexico Cyclosporine Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cyclosporine Drugs Revenue, 2018-2030
6.4.2 Germany Cyclosporine Drugs Market Size, 2018-2030
6.4.3 France Cyclosporine Drugs Market Size, 2018-2030
6.4.4 U.K. Cyclosporine Drugs Market Size, 2018-2030
6.4.5 Italy Cyclosporine Drugs Market Size, 2018-2030
6.4.6 Russia Cyclosporine Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Cyclosporine Drugs Market Size, 2018-2030
6.4.8 Benelux Cyclosporine Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cyclosporine Drugs Revenue, 2018-2030
6.5.2 China Cyclosporine Drugs Market Size, 2018-2030
6.5.3 Japan Cyclosporine Drugs Market Size, 2018-2030
6.5.4 South Korea Cyclosporine Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Cyclosporine Drugs Market Size, 2018-2030
6.5.6 India Cyclosporine Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cyclosporine Drugs Revenue, 2018-2030
6.6.2 Brazil Cyclosporine Drugs Market Size, 2018-2030
6.6.3 Argentina Cyclosporine Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cyclosporine Drugs Revenue, 2018-2030
6.7.2 Turkey Cyclosporine Drugs Market Size, 2018-2030
6.7.3 Israel Cyclosporine Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Cyclosporine Drugs Market Size, 2018-2030
6.7.5 UAE Cyclosporine Drugs Market Size, 2018-2030
7 Players Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Cyclosporine Drugs Major Product Offerings
7.1.4 AbbVie Cyclosporine Drugs Revenue in Global Market (2018-2023)
7.1.5 AbbVie Key News
7.2 Allergan
7.2.1 Allergan Corporate Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Cyclosporine Drugs Major Product Offerings
7.2.4 Allergan Cyclosporine Drugs Revenue in Global Market (2018-2023)
7.2.5 Allergan Key News
7.3 Apotex
7.3.1 Apotex Corporate Summary
7.3.2 Apotex Business Overview
7.3.3 Apotex Cyclosporine Drugs Major Product Offerings
7.3.4 Apotex Cyclosporine Drugs Revenue in Global Market (2018-2023)
7.3.5 Apotex Key News
7.4 Mayne Pharma Group
7.4.1 Mayne Pharma Group Corporate Summary
7.4.2 Mayne Pharma Group Business Overview
7.4.3 Mayne Pharma Group Cyclosporine Drugs Major Product Offerings
7.4.4 Mayne Pharma Group Cyclosporine Drugs Revenue in Global Market (2018-2023)
7.4.5 Mayne Pharma Group Key News
7.5 Mckesson Medical Surgical
7.5.1 Mckesson Medical Surgical Corporate Summary
7.5.2 Mckesson Medical Surgical Business Overview
7.5.3 Mckesson Medical Surgical Cyclosporine Drugs Major Product Offerings
7.5.4 Mckesson Medical Surgical Cyclosporine Drugs Revenue in Global Market (2018-2023)
7.5.5 Mckesson Medical Surgical Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Cyclosporine Drugs Major Product Offerings
7.6.4 Novartis Cyclosporine Drugs Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News
7.7 Otsuka Pharmaceutical
7.7.1 Otsuka Pharmaceutical Corporate Summary
7.7.2 Otsuka Pharmaceutical Business Overview
7.7.3 Otsuka Pharmaceutical Cyclosporine Drugs Major Product Offerings
7.7.4 Otsuka Pharmaceutical Cyclosporine Drugs Revenue in Global Market (2018-2023)
7.7.5 Otsuka Pharmaceutical Key News
7.8 Regenerx Biopharmaceuticals
7.8.1 Regenerx Biopharmaceuticals Corporate Summary
7.8.2 Regenerx Biopharmaceuticals Business Overview
7.8.3 Regenerx Biopharmaceuticals Cyclosporine Drugs Major Product Offerings
7.8.4 Regenerx Biopharmaceuticals Cyclosporine Drugs Revenue in Global Market (2018-2023)
7.8.5 Regenerx Biopharmaceuticals Key News
7.9 Santen Pharmaceuticals
7.9.1 Santen Pharmaceuticals Corporate Summary
7.9.2 Santen Pharmaceuticals Business Overview
7.9.3 Santen Pharmaceuticals Cyclosporine Drugs Major Product Offerings
7.9.4 Santen Pharmaceuticals Cyclosporine Drugs Revenue in Global Market (2018-2023)
7.9.5 Santen Pharmaceuticals Key News
7.10 Sun Pharmaceuticals Industries
7.10.1 Sun Pharmaceuticals Industries Corporate Summary
7.10.2 Sun Pharmaceuticals Industries Business Overview
7.10.3 Sun Pharmaceuticals Industries Cyclosporine Drugs Major Product Offerings
7.10.4 Sun Pharmaceuticals Industries Cyclosporine Drugs Revenue in Global Market (2018-2023)
7.10.5 Sun Pharmaceuticals Industries Key News
7.11 Takeda Pharmaceutical
7.11.1 Takeda Pharmaceutical Corporate Summary
7.11.2 Takeda Pharmaceutical Business Overview
7.11.3 Takeda Pharmaceutical Cyclosporine Drugs Major Product Offerings
7.11.4 Takeda Pharmaceutical Cyclosporine Drugs Revenue in Global Market (2018-2023)
7.11.5 Takeda Pharmaceutical Key News
7.12 Teva Pharmaceuticals Industries
7.12.1 Teva Pharmaceuticals Industries Corporate Summary
7.12.2 Teva Pharmaceuticals Industries Business Overview
7.12.3 Teva Pharmaceuticals Industries Cyclosporine Drugs Major Product Offerings
7.12.4 Teva Pharmaceuticals Industries Cyclosporine Drugs Revenue in Global Market (2018-2023)
7.12.5 Teva Pharmaceuticals Industries Key News
7.13 United Biotech
7.13.1 United Biotech Corporate Summary
7.13.2 United Biotech Business Overview
7.13.3 United Biotech Cyclosporine Drugs Major Product Offerings
7.13.4 United Biotech Cyclosporine Drugs Revenue in Global Market (2018-2023)
7.13.5 United Biotech Key News
7.14 Huadong Medicine
7.14.1 Huadong Medicine Corporate Summary
7.14.2 Huadong Medicine Business Overview
7.14.3 Huadong Medicine Cyclosporine Drugs Major Product Offerings
7.14.4 Huadong Medicine Cyclosporine Drugs Revenue in Global Market (2018-2023)
7.14.5 Huadong Medicine Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cyclosporine Drugs Market Opportunities & Trends in Global Market
Table 2. Cyclosporine Drugs Market Drivers in Global Market
Table 3. Cyclosporine Drugs Market Restraints in Global Market
Table 4. Key Players of Cyclosporine Drugs in Global Market
Table 5. Top Cyclosporine Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cyclosporine Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cyclosporine Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cyclosporine Drugs Product Type
Table 9. List of Global Tier 1 Cyclosporine Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cyclosporine Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cyclosporine Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cyclosporine Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cyclosporine Drugs Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Cyclosporine Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cyclosporine Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cyclosporine Drugs Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Cyclosporine Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cyclosporine Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cyclosporine Drugs Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Cyclosporine Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cyclosporine Drugs Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Cyclosporine Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cyclosporine Drugs Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Cyclosporine Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cyclosporine Drugs Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Cyclosporine Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cyclosporine Drugs Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Cyclosporine Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cyclosporine Drugs Revenue, (US$, Mn), 2023-2030
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Cyclosporine Drugs Product Offerings
Table 32. AbbVie Cyclosporine Drugs Revenue (US$, Mn), (2018-2023)
Table 33. Allergan Corporate Summary
Table 34. Allergan Cyclosporine Drugs Product Offerings
Table 35. Allergan Cyclosporine Drugs Revenue (US$, Mn), (2018-2023)
Table 36. Apotex Corporate Summary
Table 37. Apotex Cyclosporine Drugs Product Offerings
Table 38. Apotex Cyclosporine Drugs Revenue (US$, Mn), (2018-2023)
Table 39. Mayne Pharma Group Corporate Summary
Table 40. Mayne Pharma Group Cyclosporine Drugs Product Offerings
Table 41. Mayne Pharma Group Cyclosporine Drugs Revenue (US$, Mn), (2018-2023)
Table 42. Mckesson Medical Surgical Corporate Summary
Table 43. Mckesson Medical Surgical Cyclosporine Drugs Product Offerings
Table 44. Mckesson Medical Surgical Cyclosporine Drugs Revenue (US$, Mn), (2018-2023)
Table 45. Novartis Corporate Summary
Table 46. Novartis Cyclosporine Drugs Product Offerings
Table 47. Novartis Cyclosporine Drugs Revenue (US$, Mn), (2018-2023)
Table 48. Otsuka Pharmaceutical Corporate Summary
Table 49. Otsuka Pharmaceutical Cyclosporine Drugs Product Offerings
Table 50. Otsuka Pharmaceutical Cyclosporine Drugs Revenue (US$, Mn), (2018-2023)
Table 51. Regenerx Biopharmaceuticals Corporate Summary
Table 52. Regenerx Biopharmaceuticals Cyclosporine Drugs Product Offerings
Table 53. Regenerx Biopharmaceuticals Cyclosporine Drugs Revenue (US$, Mn), (2018-2023)
Table 54. Santen Pharmaceuticals Corporate Summary
Table 55. Santen Pharmaceuticals Cyclosporine Drugs Product Offerings
Table 56. Santen Pharmaceuticals Cyclosporine Drugs Revenue (US$, Mn), (2018-2023)
Table 57. Sun Pharmaceuticals Industries Corporate Summary
Table 58. Sun Pharmaceuticals Industries Cyclosporine Drugs Product Offerings
Table 59. Sun Pharmaceuticals Industries Cyclosporine Drugs Revenue (US$, Mn), (2018-2023)
Table 60. Takeda Pharmaceutical Corporate Summary
Table 61. Takeda Pharmaceutical Cyclosporine Drugs Product Offerings
Table 62. Takeda Pharmaceutical Cyclosporine Drugs Revenue (US$, Mn), (2018-2023)
Table 63. Teva Pharmaceuticals Industries Corporate Summary
Table 64. Teva Pharmaceuticals Industries Cyclosporine Drugs Product Offerings
Table 65. Teva Pharmaceuticals Industries Cyclosporine Drugs Revenue (US$, Mn), (2018-2023)
Table 66. United Biotech Corporate Summary
Table 67. United Biotech Cyclosporine Drugs Product Offerings
Table 68. United Biotech Cyclosporine Drugs Revenue (US$, Mn), (2018-2023)
Table 69. Huadong Medicine Corporate Summary
Table 70. Huadong Medicine Cyclosporine Drugs Product Offerings
Table 71. Huadong Medicine Cyclosporine Drugs Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Cyclosporine Drugs Segment by Type in 2022
Figure 2. Cyclosporine Drugs Segment by Application in 2022
Figure 3. Global Cyclosporine Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cyclosporine Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cyclosporine Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cyclosporine Drugs Revenue in 2022
Figure 8. By Type - Global Cyclosporine Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cyclosporine Drugs Revenue Market Share, 2018-2030
Figure 10. By Region - Global Cyclosporine Drugs Revenue Market Share, 2018-2030
Figure 11. By Country - North America Cyclosporine Drugs Revenue Market Share, 2018-2030
Figure 12. US Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Cyclosporine Drugs Revenue Market Share, 2018-2030
Figure 16. Germany Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. France Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Cyclosporine Drugs Revenue Market Share, 2018-2030
Figure 24. China Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 28. India Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Cyclosporine Drugs Revenue Market Share, 2018-2030
Figure 30. Brazil Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Cyclosporine Drugs Revenue Market Share, 2018-2030
Figure 33. Turkey Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Cyclosporine Drugs Revenue, (US$, Mn), 2018-2030
Figure 37. AbbVie Cyclosporine Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Allergan Cyclosporine Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Apotex Cyclosporine Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Mayne Pharma Group Cyclosporine Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Mckesson Medical Surgical Cyclosporine Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Cyclosporine Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Otsuka Pharmaceutical Cyclosporine Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Regenerx Biopharmaceuticals Cyclosporine Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Santen Pharmaceuticals Cyclosporine Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sun Pharmaceuticals Industries Cyclosporine Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Takeda Pharmaceutical Cyclosporine Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Teva Pharmaceuticals Industries Cyclosporine Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. United Biotech Cyclosporine Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Huadong Medicine Cyclosporine Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
